Loading Events

« All Events

  • This event has passed.

Be part of the ctDNA pilot for lung cancer patients

April 17 @ 4:00 PM - 5:00 PM

Details of an online session which will share details of the next phase of the ctDNA pilot for lung cancer patients.

Details of an online session which will share details of the next phase of the ctDNA pilot for lung cancer patients.

We are looking for NEW sites to join our ctDNA pilot for suspected lung cancer. Come and find out how you can get involved.

This session will provide details about the ctDNA pilot and the logistics for the South East.

It is relevant to:

  • Any healthcare professionals who are interested in getting involved in the pilot
  • Sites already involved who would like information on the new process

New funding has just been announced to continue, and expand, the national circulating tumour DNA pilot in non-small cell lung cancer in the South East England region (South London, Kent, Surrey, Sussex).

We are seeking more hospitals to get involved to diagnose patients with radiologically suspected grade 3 or 4 lung cancer via a blood test using circulating tumour DNA (ctDNA).

This part of a national pilot which is looking to understand the potential benefits of embedding ctDNA testing for suspected lung cancer in the NHS.

Sign up to this information session or get in touch with Wes on Wesley.Pigg@gstt.nhs.uk

Details

Date:
April 17
Time:
4:00 PM - 5:00 PM
Event Categories:
,
Event Tags:
, , ,

Venue

Online
United Kingdom

Organiser

NHS South East Genomic Medicine Service Alliance
Email
gst-tr.southeastgmsa@nhs.net
View Organiser Website
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
 
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.